Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,807,742 papers from all fields of science
Search
Sign In
Create Free Account
glatiramer acetate
Known as:
COP-1
, L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
, Copolymer-1
Expand
A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
1 ML glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone]
Drug Allergy
In Blood
Multiple Sclerosis, Relapsing-Remitting
Expand
Broader (4)
Antirheumatic Agents
Glatiramer
Immunologic Adjuvants
Immunosuppressive Agents
Narrower (3)
Copaxone
Glatopa
TV 5010
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Comparative studies of glatiramer acetate and interferon beta.
D. Goodin
International MS journal
2008
Corpus ID: 43393040
Over the last decade and a half, several disease-modifying therapies (DMTs) have been approved for the treatment of multiple…
Expand
2006
2006
Glatiramer acetate-induced lipoathrophy
U. Wollina
2006
Corpus ID: 78060212
A 42-year old woman presented with an almost symmetrical loss of subcutaneous adipose tissue of the outer upper legs. She…
Expand
Review
2005
Review
2005
Mitoxantrone in the treatment of multiple sclerosis.
Morrissey Sp
,
E. Lepage
,
G. Edan
International MS journal
2005
Corpus ID: 19148381
Mitoxantrone is useful for the treatment of cancer and MS and, as with other chemotherapeutic agents, many studies have examined…
Expand
2003
2003
Dermite livedoïde de Nicolau après injection de Copolymère-1 (Acétate de Glatiramer)
C. Gaudez
,
S. Régnier
,
S. Aractingi
,
O. Heinzlef
2003
Corpus ID: 196175848
Nous rapportons le premier cas de dermite livedoide de Nicolau apres injection de Copolymere-1. Celle-ci est caracterisee par une…
Expand
2002
2002
Treatment of multiple sclerosis with newer immune-modulating drugs
I. Taylor
,
R. Macdonell
,
J. Coleman
2002
Corpus ID: 75902173
Multiple sclerosis can be a severely disabling disease. Recently introduced immunomodulatory drugs
2001
2001
Glatiramer acetate (Copaxone).
F. da
2001
Corpus ID: 53766097
: Glatiramer acetate (Copaxone) is a novel preparation of synthetic peptides composed of four amino acids. Laboratory studies…
Expand
2001
2001
Traitement des formes évolutives de SEP
G. Edan
2001
Corpus ID: 196463164
Les formes evolutives de SEP n'ont pas fait l'objet d'une definition de reference. De facon arbitraire, nous avons designe sous…
Expand
Review
1999
Review
1999
Overview of the UNFCCC AIJ activities implemented jointly pilot: COP-1 decision 5, reporting guidelines and case studies
C. Jepma
,
R. K. Dixon
,
M. Eisma
1999
Corpus ID: 70818910
The activities implemented jointly (AIJ) pilot was established by Decision 5 of the UN Framework Convention on Climate Change…
Expand
1996
1996
Treatment of Multiple Sclerosis with Methotrexate
Donald Eliot Goodkin
,
J. Fischer
1996
Corpus ID: 68356358
Considerable evidence supports the hypothesis that multiple sclerosis (MS) is an autoimmune disease associated with heightened…
Expand
1988
1988
Copolymer 1 as therapy for multiple sclerosis: The cons
R. Baumhefner
,
W. Tourtellotte
,
K. Syndulko
,
P. Shapshak
,
M. Osborne
,
G. Rubinshteĭn
Neurology
1988
Corpus ID: 23857119
&NA; —One of the hallmarks of multiple sclerosis (MS) is intra‐blood‐brain‐barrier (BBB) IgG synthesis, a byproduct of plasma…
Expand